Topic Cardiac resynchronization therapy
Methods Employed to Assess Left Ventricular Ejection Fraction in Patients Referred for Cardiac Resynchronization Therapy in Poland as Compared to other European Countries. Results from the European Cardiac Resynchronization Therapy Survey II.
Damian Łasocha, Mateusz Tajstra, Krystian Josiak, Dariusz Zając, Kenneth Dickstein, Cecilia Linde, Camilla Normand, Łukasz J. Szumowski, Maciej Sterliński
Heart Beat 2019;4:34–39
To replace or to abandon and implant a new lead? Conservative approach creates new challenges (and risks) for the patients in future. Should we still wait for class 1 indications ? Case report and discussion of the problem.
Paweł Stefańczyk, Wojciech Borzęcki, Łukasz Tułecki, Konrad Tomków, Dorota Nowosielecka, Andrzej Kleinrok, Andrzej Kutarski
Heart Beat 2019;4:16–19
A rare complication: Right Contralateral Hemopneumothorax After Pacemaker Implantation
Heart Beat 2019;4:8–10
Left bundle branch block and peripartum cardiomyopathy – review on recent evidence
Heart Beat 2018;3:117–119
Implantation of cardiac resynchronization therapy through persistent left superior vena cava.
Heart Beat 2018;3:77–79
The latest research in telecardiology presented on ESC Congress 2018
Heart Beat 2018;3:69–71
No benefits from exercise training and worse outcomes in heart failure patients with atrial fibrillation and cardiovascular implantable electronic devices.
Rafał Dąbrowski, Edyta Smolis-Bąk, Ilona Kowalik, Marcin Dobrowolski, Justyna Mączynska, Laura Załucka, Hanna Rymuza, Barbara Jędrzejczyk, Maciej Sterliński, Mariusz Pytkowski, Hanna Szwed
Heart Beat 2018;3:61–68
Sacubitril/valsartan and the risk of sudden cardiac death
Heart Beat 2018;3:59–60
What is the conclusion from the DECODE CRT-D study?
Heart Beat 2018;3:54–55
Left Ventricular Pacing via Coronary Sinus in a Patient With a Mechanical Tricuspid Valve.
Jakub Zawadzki, Łukasz Januszkiewicz, Andrzej Cacko, Marcin Michalak, Grzegorz Opolski, Marcin Grabowski
Heart Beat 2017;2:36–37
Relation between left ventricular wall dimensions in cardiac resynchronization therapy candidates and echocardiographic and clinical outcome.
Heart Beat 2017;2:27–32
